They will come out of the woodwork. Dealing with that right now @ AVNR. Nuedexta has been on the market for 3 years. Sales run rate about $125 mil annually right now. Generic companies in court trying to get rights to generic version. They didn't spend one cent developing or testing this drug, but they sure want to sell it.